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ioninvasive Detection of
ulnerable Plaques
re We There Yet?
e read with great interest the study by Motoyama et al. (1)
emonstrating that patients with low-attenuation and positively
emodeled plaques—as detected by computed tomography angiog-
aphy (CTA)—were more likely to suffer from acute coronary
yndromes (ACS) during follow-up. A total of 10,037 coronary
egments 2 mm in diameter were analyzed in 1,059 patients;
fter a follow-up 2 years, 15 of these patients suffered ACS.
dverse CTA features (remodelling and/or low attenuation) were
owerful predictors of ACS development after adjustment (hazard
atio: 22.8). This study is provocative indeed, considering that, up
o now, the diagnosis of vulnerable plaque (VP) (defined as those
t higher risk for future rupture/thrombosis) has been elusive (2).
n fact, despite the use of sophisticated and highly accurate
ntracoronary diagnostic techniques (intravascular ultrasound, vir-
ual histology, elastography, thermography, coronary angioscopy,
nd optical coherence tomography) the identification of VP has
een not only a moving target but also clinically unreliable (2–5).
urrently, with invasive techniques, unique insights on plaque
haracteristics including morphology, composition, physiologic
roperties, and even measurements of local temperature, macro-
hage content and fibrous cap thickness can be obtained; yet we
annot accurately predict their prognosis (2–5).
Addressing some methodological issues would be highly appre-
iated, considering the potential major implications of the present
tudy (1). First, data confirming that the detected ACS were in fact
elated to the coronary segment presenting adverse CTA features
eems crucial. Therefore, electrocardiographic or angiographic
ndings correlating ACS episodes with the target vessel/lesion
ould be reassuring. Conversely, if events arose from other
oronary segments, the information would be difficult to interpret.
his is particularly worrisome, considering the study definition of
CS (troponin rise was not required) and that up to 651 segments
excluded from CTA analysis) had previous/scheduled coronary
nterventions. Second, all patients had established or suspected
oronary artery disease; however, information on clinical presen-
ation (asymptomatic, stable angina, stabilized unstable angina)
ould be of relevance to better define the population risk profile.
hird, only 45 patients (4.5%) presented plaques with both
ttenuation and positive remodelling. Nevertheless, in similar
atient cohorts, intravascular ultrasound studies frequently detect
ultiple nonocclusive plaques with low-echogenicity or significant
ecrotic cores, associated with positive remodelling (2–5). Accord-
ngly, additional explanations on CTA plaque characterization
ould be of value to reconcile these apparent discordant results.
ourth, up to 22% of patients harboring plaques with both adverse
ndings suffered ACS; this is a striking figure, considering the
elatively low-risk patient population analyzed. Finally, we should ieep in mind that ACS emerge from heterogeneous substrates.
rosion of fibrotic plaques, calcified nodules, and intra-plaque
emorrhage are well-recognized underlying substrates of ACS all
acking the distinct morphologic features of thin-cap fibroathe-
oma (2).
We fully agree with the authors’ suggestion that additional
tudies are required to demonstrate the value of CTA to identify
he “highly elusive” VP. If the value of CTA to accurately identify
igh-risk plaques is confirmed (possibly with the additional help of
ystemic biomarkers), the dawn of a new era—namely that of
pplying aggressive preventive interventions (intensive systemic
herapy or intracoronary stenting) to “passivate” these plaques—
ill undoubtedly begin.
Fernando Alfonso, SD
Hospital Clinico San Carlos
nterventional Cardiology
laza Cristo Rey
adrid 28040
pain
-mail: falf@hotmail.com
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eply
e thank Dr. Alfonso for interest in our manuscript and very
nsightful comments. We agree that feasibility of noninvasive identi-
cation of plaques vulnerable to rupture might have significant clinical
mplications, and clarify here the methodological issues raised. As
escribed in our paper (1), acute coronary syndromes (ACS)
ncluded acute myocardial infarction with the elevation of troponin
evel and unstable angina without troponin elevation. Our report
haracterized the plaques that resulted in ACS and excluded the
esions already subjected to intervention or those selected for
ntervention. As noted in the report, 3 patients developed ACS
nvolving the previously treated lesion and were excluded from the
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March 16, 2010:1163–7nalysis. Also, target lesion could not be identified in 8 patients
ith ACS, because of multiple vessel disease, and were excluded.
urthermore, the lower proportion of 2-feature positive plaques in
ur report is because of different study populations; most of the
ntravascular ultrasound studies had included patients who needed
ercutaneous coronary intervention. The range of Framingham
isk score in the patients with 1- or 2-feature positive was 3 to 56;
he risk score in the patients with 1-feature positive plaques was 16
8 and 19  13 for patients showing 2-feature positive plaques.
e agree with Dr. Alfonso that plaque rupture does not provide a
omplete spectrum of ACS. It would be necessary to develop
trategies for identification of plaques resulting in ACS from
laque erosions and calcified nodules. However, identification of
uch substrates at least by computed tomography angiography
ould be rather difficult.
adako Motoyama, MD, PhD
ukio Ozaki, MD, PhD
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iastolic Dysfunction in Aortic
tenosis and Arterial Stiffness
read with interest the recent paper (1) describing increased
ortality in asymptomatic patients with at least moderate aortic
tenosis (AS) who have an increased valvuloarterial impedance
Zva) (total left ventricular [LV] afterload including arterial pres-
ure). Total LV afterload explains 2 common scenarios often
ncountered in clinical practice, that of severe AS associated with
ow aortic valve gradient and normal LV systolic function as well
s that of symptoms in some patients with moderate AS. The
rticle implies that the phenomenon of low cardiac output is
elated to increased LV afterload from both AS and systemic
rterial hypertension. I would propose another variable that con-
ributes to low cardiac output as well as heart failure symptoms in
his cohort , that of ventricular stiffening and diastolic dysfunction.
rterial stiffness is associated with diastolic LV dysfunction (2).
side from LV afterload, LV pre-load and diastolic filling param-
ters may contribute significantly to the reduced stroke volume and
ardiac output. Enlarged left atrial volume index as well as grade II
r greater diastolic dysfunction, indicating compliance abnormality
nd elevated LV end diastolic pressure may be indicators of
iastolic dysfunction in this group. A review of Table 1 in their
ata (1) shows that diastolic dysfunction prevalence was compa- hable in patients with the 3 categories of Zva 3.5, 3.5 to 4.5, and
4.5 mm Hg/ml. However, the grade of diastolic dysfunction was
ot quantified or presented. Diastolic dysfunction is expected in
his cohort of patients with AS, increased LV mass, hypertension,
nd mean age of 66 years. However, it is the grade of diastolic
ysfunction that may help to determine its potential role in causing
educed LV diastolic volume as well as potentially increased
ulmonary venous congestion and elevated pulmonary artery pres-
ure, and in turn, heart failure symptoms. The data on pulmonary
rtery pressure also are not presented in their report. Table 1 of
achicha et al. (1) does show reduced diastolic volume (96  25
l vs. 111  27 ml) in those in the highest Zva versus lowest Zva
roups. Although increased relative wall thickness may explain
educed diastolic volume, diastolic dysfunction may be an impor-
ant contributor. In addition, atrial fibrillation, another common
linical problem in this group of patients, may coexist, further
educing the atrial contribution to cardiac output. It remains
nclear from the report whether patients with atrial fibrillation
ere included. Evaluation of both LV pre-load and afterload,
long with hemodynamics of aortic valve obstruction, may be
mportant parameters to evaluate in clinical practice in patients
ith AS.
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sefulness of Valvuloarterial
mpedance to Predict Adverse
utcomes in Patients With
symptomatic Aortic Stenosis
achicha et al. (1) have proposed the use of valvuloarterial
mpedance (Zva) to improve risk stratification and clinical decision
aking in patients with asymptomatic severe aortic stenosis (AS).
owever, some questions remain unanswered.
The first critical task in the management of AS is accurate
ssessment of its severity and overall clinical impact. Because Zva
oes not separate relative contributions of AS and the associated
ypertension, high resistance, and low arterial compliance of the
